These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Lacout C; Pisani DF; Tulliez M; Gachelin FM; Vainchenker W; Villeval JL Blood; 2006 Sep; 108(5):1652-60. PubMed ID: 16670266 [TBL] [Abstract][Full Text] [Related]
50. Differential NOD/SCID mouse engraftment of peripheral blood CD34+ cells and JAK2V617F clones from patients with myeloproliferative neoplasms. Fung TK; Cheung AM; Kwong YL; Liang R; Leung AY Leuk Res; 2010 Oct; 34(10):1390-4. PubMed ID: 20170959 [TBL] [Abstract][Full Text] [Related]
51. Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis. Moura LG; Tognon R; Nunes NS; Rodrigues LC; Ferreira AF; Kashima S; Covas DT; Santana M; Souto EX; Perobelli L; Simões BP; Dias-Baruffi M; Castro FA J Clin Pathol; 2016 Oct; 69(10):926-9. PubMed ID: 27402956 [TBL] [Abstract][Full Text] [Related]
52. Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET). Zhao S; Zhang X; Xu Y; Feng Y; Sheng W; Cen J; Wu D; Han Y Int J Med Sci; 2016; 13(1):85-91. PubMed ID: 26917989 [TBL] [Abstract][Full Text] [Related]
53. [Expression of apoptosis related proteins in CD34 positive bone marrow cells of patients with polycythemia vera]. Bai J; Shao ZH; Liu H; Shi J; Cao YR; Tu MF; Wu YH; Jia HR; Sun J; Cui ZZ; Qian LS; Yang CL Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):617-20. PubMed ID: 15634597 [TBL] [Abstract][Full Text] [Related]
54. Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. Mullally A; Bruedigam C; Poveromo L; Heidel FH; Purdon A; Vu T; Austin R; Heckl D; Breyfogle LJ; Kuhn CP; Kalaitzidis D; Armstrong SA; Williams DA; Hill GR; Ebert BL; Lane SW Blood; 2013 May; 121(18):3692-702. PubMed ID: 23487027 [TBL] [Abstract][Full Text] [Related]
55. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Jamieson CH; Gotlib J; Durocher JA; Chao MP; Mariappan MR; Lay M; Jones C; Zehnder JL; Lilleberg SL; Weissman IL Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6224-9. PubMed ID: 16603627 [TBL] [Abstract][Full Text] [Related]
56. A novel zebrafish jak2a(V581F) model shared features of human JAK2(V617F) polycythemia vera. Ma AC; Fan A; Ward AC; Liongue C; Lewis RS; Cheng SH; Chan PK; Yip SF; Liang R; Leung AY Exp Hematol; 2009 Dec; 37(12):1379-1386.e4. PubMed ID: 19772888 [TBL] [Abstract][Full Text] [Related]
57. Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells. Lu M; Wang X; Li Y; Tripodi J; Mosoyan G; Mascarenhas J; Kremyanskaya M; Najfeld V; Hoffman R Blood; 2012 Oct; 120(15):3098-105. PubMed ID: 22872685 [TBL] [Abstract][Full Text] [Related]
58. A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm. Casolari DA; Nguyen T; Butcher CM; Iarossi DG; Hahn CN; Bray SC; Neufing P; Parker WT; Feng J; Maung KZY; Wee A; Vidovic L; Kok CH; Bardy PG; Branford S; Lewis ID; Lane SW; Scott HS; Ross DM; D'Andrea RJ Sci Rep; 2017 May; 7(1):2467. PubMed ID: 28550306 [TBL] [Abstract][Full Text] [Related]
59. JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway. De Grandis M; Cambot M; Wautier MP; Cassinat B; Chomienne C; Colin Y; Wautier JL; Le Van Kim C; El Nemer W Blood; 2013 Jan; 121(4):658-65. PubMed ID: 23160466 [TBL] [Abstract][Full Text] [Related]
60. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia. Bellucci S; Michiels JJ Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]